Blue Shield of California Slashes Cost of World's Best-Selling Drug
October 02, 2024
October 02, 2024
SAN FRANCISCO, California, Oct. 2 -- The Blue Shield of California issued the following news release:
* * *
Nonprofit health plan collaborates with Fresenius Kabi and Evio Pharmacy Solutions to purchase FDA-approved Humira biosimilar for $525 per monthly dose, compared to the market reported net price of Humira at $2,100.
* * *
* New drug available for most members at $0 co-pay starting January 1, 2025 when Blue Shield launches Pharmacy Care Re . . .
* * *
Nonprofit health plan collaborates with Fresenius Kabi and Evio Pharmacy Solutions to purchase FDA-approved Humira biosimilar for $525 per monthly dose, compared to the market reported net price of Humira at $2,100.
* * *
* New drug available for most members at $0 co-pay starting January 1, 2025 when Blue Shield launches Pharmacy Care Re . . .